The San Diego Guide to Ketamine and Psychedelic Therapy

The Options in San Diego, Briefly

There are a handful of distinct ways to pursue ketamine or psychedelic therapy in San Diego. Here is what each one actually is, without ranking them.

• At-home ketamine therapy (telehealth). Clinician-guided ketamine therapy done from home, with medication shipped to you and sessions supported remotely. Mindbloom is one provider in this category and works with eligible adults after an online evaluation.
• In-clinic ketamine (IV or IM). Infusions or injections given in a medical office with on-site monitoring. In San Diego, Pacific Psych Centers in Del Mar offers IV and IM ketamine, and Kai MacDonald Ketamine Clinic in Bankers Hill offers a concierge in-clinic option.¹² ¹³
• Spravato (esketamine). An FDA-approved esketamine nasal spray given in a certified clinic under monitoring. San Diego providers include Kadima Neuropsychiatry in La Jolla and SD Wellness Group in Hillcrest. It may be covered by insurance for people who qualify, subject to prior authorization.
• Licensed in-clinic psilocybin. Not an option in California. Psilocybin is Schedule I statewide with no licensed service program, unlike Oregon or Colorado.¹¹
• Clinical trials. Research studies are the other legal route to investigational psychedelics such as MDMA or psilocybin, when trials are enrolling. Availability is limited and never guaranteed.

Which One Fits You

A quick way to narrow the options, matched to what you care about most:

• Prefer a supervised, in-office experience: in-clinic IV or IM ketamine at a San Diego clinic.
• Have treatment-resistant depression and want to use insurance where possible: Spravato at a certified clinic, subject to your insurer's approval.
• Want privacy, flexible scheduling, and treatment from home: at-home ketamine therapy via telehealth, such as Mindbloom, for eligible adults.
• Set on psilocybin or MDMA specifically: a clinical trial or travel to Colorado or Oregon, since neither is legally available for therapy in California.

Where Ketamine and Psychedelic Therapy Is Available Across San Diego County

At-home telehealth care reaches every part of San Diego County, so where you live rarely limits access. In-clinic options cluster in a few areas: Del Mar and the North County coast (Carlsbad, Encinitas, Oceanside), La Jolla, and central neighborhoods like Hillcrest, Bankers Hill, and the College Area near San Diego State University.

Residents of Chula Vista, El Cajon, Escondido, Coronado, and Point Loma can reach in-clinic care in those hubs, or start at-home ketamine therapy in California without traveling at all. Because at-home care is delivered by telehealth, ketamine therapy in a suburb like Carlsbad or Chula Vista works the same as it does downtown.

Is Ketamine Legal in California? Is Psychedelic Therapy Legal in San Diego?

Ketamine is legal in California and across all 50 states. It is an FDA-approved, Schedule III medication that a licensed clinician can prescribe off-label for mental health, which is why it is available now, both in San Diego clinics and at home via telehealth for eligible adults.

Psilocybin and MDMA are a different story. Both are Schedule I under California law, with no licensed psychedelic-therapy program like Oregon's or Colorado's. San Diego has not passed a local decriminalization or deprioritization measure, unlike Oakland, San Francisco, Santa Cruz, Berkeley, Arcata, and Eureka, so statewide Schedule I rules apply here in full.¹¹ In practice, that means ketamine is the psychedelic-class psychedelic therapy you can legally begin in San Diego today. That direction has federal momentum behind it: in April 2026 a federal executive order directed the FDA and DEA to accelerate research into and access to psychedelic therapies, including ketamine, the one already available under medical supervision today.¹⁴

Why People Choose At-Home Care

For people who choose to do ketamine therapy from home, the reasons are usually privacy, flexible scheduling, and cost, backed by a growing evidence base. Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes draw on a peer-reviewed subcutaneous study (Parks 2026) covering depression, anxiety, and PTSD in one study, alongside two earlier peer-reviewed sublingual studies (Hull 2022, Mathai 2024) and research preprints extending to grief, burnout, and sleep, the largest published evidence base in at-home ketamine therapy.¹ ² For San Diego's large military and veteran population, one point stands out: Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes.¹

Mindbloom's Psychedelic Therapy Programs and Outcomes

_{Table notes. ¹ Subcutaneous, six-session course (Parks 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9/GAD-7 under 5, or at least a 10-point reduction with PCL-5 under 33. ⁶ Grief (Swain, PGD-13). ⁷ Burnout (Swain, MBI-GS). ⁸ Sleep (Swain, PHQ-9 Item 3); single-item measure, ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1%). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution. Individual results vary.}

Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

A few study-vs-study comparisons put those numbers in context:

• Mindbloom's reported depression response is comparable to the rate reported in a study of first-line SSRIs, without a daily medication and faster (2 sessions vs four to six weeks).¹ ³
• Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety (60.6% vs 47%), in about half the time.¹ ⁴
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time (76% response, within its 66–82% range, reached in about 6 sessions versus 16).⁵ ⁶
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37–42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁹

Across both routes, serious adverse events occurred in fewer than 0.1% of participants.¹ ²

How At-Home Ketamine Therapy Works

Ketamine works differently from a daily antidepressant. It acts on the brain's NMDA receptors and stimulates neuroplasticity, the brain's ability to form new connections, which can lift mood quickly and, over a course of sessions, help those gains hold. Many people notice an early shift, with cumulative benefit building across the program rather than from a single session.

The at-home model starts with an online clinical evaluation. A licensed clinician reviews your history and decides whether ketamine therapy is a good fit and, if so, prescribes it with a personalized, clinician-guided schedule rather than a fixed cadence. Sessions are done at home with preparation and integration support, and your progress is monitored throughout.

The Conditions Ketamine Therapy Is Used For

Depression is the flagship indication and the most studied, including ketamine treatment for depression that has not responded to other options. Ketamine therapy is also used for anxiety, grief, burnout, and sleep, each covered in the outcomes above.

PTSD deserves its own line in San Diego. With one of the country's largest active-duty and veteran populations, demand for effective PTSD care is high, and interest in MDMA-assisted therapy for PTSD is common. MDMA-assisted therapy is not FDA-approved or available, so the accessible, evidence-backed path today is ketamine therapy, where Mindbloom reported a 76.7% response rate and 56.7% remission for PTSD over a six-session course.¹

Cost, Insurance, and Getting Started

In-clinic ketamine in San Diego runs roughly $450 to $650 or more per session, and one Del Mar clinic contracts with Kaiser Permanente of San Diego for referred patients.¹² ¹³ Spravato may be covered by insurance for people who qualify, subject to prior authorization. At-home ketamine therapy with Mindbloom is $165 to $215 per session within a multi-session program (6, 12, or 18 sessions), is HSA and FSA eligible, and may qualify for out-of-network reimbursement. Current pricing and program details are listed by session count.

Whichever path fits, ketamine therapy is a prescription medical treatment, not a retail product. Eligibility begins with an online clinician evaluation, and a licensed clinician confirms it is a good fit before treatment starts. You can read more in the Mindbloom overview or begin an eligibility evaluation online.